Abstract
Protumorigenic PD-1hi B cells, induced in hepatocellular carcinoma, suppress tumor-specific T-cell response via IL10-dependent pathways upon PD-1/PD-L1 interaction. Anti–PD-1 or anti–PD-L1 antibodies may function not only through blocking the PD-1 coinhibitory pathway in T cells but also via abolishing the suppressive function of regulatory B cells.
Original language | English (US) |
---|---|
Pages (from-to) | 477-478 |
Number of pages | 2 |
Journal | Cancer discovery |
Volume | 6 |
Issue number | 5 |
DOIs | |
State | Published - May 2016 |
ASJC Scopus subject areas
- Oncology